The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants

By Staff Reporters

President Joe Biden announced yesterday that the manufacturers of all of the first 10 prescription drugs selected for Medicare’s first price negotiations have agreed to participate, clearing the way for talks that could lower their costs in coming years and give him a potential political win heading into next year’s election.

***

Wall Street SANK Tuesday as it focuses on the downside of a surprisingly strong job market. The S&P 500 was 1.5% lower in late trading and nearly back to where it was in May. The Dow Jones Industrial Average was down 475 points, or 1.4%, at 32,957 and wiped out the last of its gains made for the year so far. The NASDAQ composite was leading the market lower with a 2% drop as Big Tech stocks were among the market’s biggest losers.

***

The 16-year high on 10-year yields is probably the biggest factor weighing on equities. So, here is where the major benchmarks ended:

• The S&P 500 Index was down 58.94 points (1.4%) at 4,229.45; the Dow Jones Industrial Average was down 430.97 points (1.3%) at 33,002.38; the NASDAQ Composite was down 248.31 points (1.9%) at 13,059.47.
• The 10-year Treasury note yield was up about 11 basis points at 4.791%.
• CBOE’s Volatility Index was up 2.17 at 19.78.

Energy shares were among the few gainers, as WTI crude oil futures rose for the first time in four sessions after dropping sharply from a 13-month high above $95 a barrel. The U.S. dollar index (DXY) strengthened for a third-straight day, touching its highest level since November, reflecting expectations that rates will remain high.

***

COMMENTS APPRECIATED

Thank You

***

***

Filed under: "Ask-an-Advisor", "Doctors Only", Accounting, Alerts Sign-Up, Drugs and Pharma, Ethics, Investing | Tagged: CBOE, Centers for Medicare & Medicaid Services, CMS, CMSS, crdue oil, DJIA, DOW, Dow Jones Industrial Average, drug negotiations, drug prices, DXY, energy, market frops, medicare, medicare drug prices, NSDAQ, oil, Russell 2000, S&P 500, VIX, WTI | Leave a comment »